ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

Centers Can Collaborate Well with Industry, Albert LoBuglio Says

May 7, 1999

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

August 15, 1980

In Brief: Construction Grant Application Deadline for 75-25% Funding Oct. 1; Fordham Quits

April 29, 1977

Judge Rules First Amendment Protects Distribution Of Off-Label Use Information

August 14, 1998

Markup Completed On Senate Cancer Act Renewal; Waxman Agrees To $90 Million Centers Line Item

May 2, 1980

In Brief: Peter Pisters named CEO of University Health Network in Toronto

August 8, 2014